<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<jPostDataset id="JPST000355" formatVersion="1.0">
  <Project id="JPST000355" pxid="PXD008331" createdDate="2017-11-22" modifiedDate="2017-11-30" mode="partial" type="Mass spectrometry">
    <Title>Glioma initiating/stem cells, differentiation, iTRAQ analysis by TT5600</Title>
    <Description>Glioma initiating/stem cells (GIC/GSC) are considered responsible for the therapeutic resistance and recurrence of malignant glioma. To clarify the molecular mechanism of GIC/GSC maintenance/differentiation, we established GIC/GSC clones, having the potential to differentiate into malignant gliomas, from glioblastoma patientâ€™s tissues, and subjected to DNA microarray/iTRAQ based integrated proteomics. 21,857 mRNAs and 8,471 proteins were identified and integrated into a gene/protein expression analysis chart (iPEACH). The data integration and extraction of global proteins and mRNAs revealed that, during the GIC/GSC differentiation, cell adhesion molecules including integrin aV/ECMs and RAS-MAPK/PI3K signalings were significantly up-regulated, meanwhile, SOX2, CD133, and specific proteoglycans/synthetic-enzymes/metabolic pathways were obviously down-regulated. Among them, we focused proteoglycans and their synthetic-enzymes. GIC/GSC differentiation was significantly associated with the decrease of CSPG (CS-modified form) and dramatically induced by the CS-degradation enzyme which also induces the up-regulation of ERK-AKT signaling and GFAP without any other agents. Importantly, these differentiation processes were also associated with the interaction of CSPG (CS-unmodified form) and integrin-aV, and suppressed by integrin-inhibitors/CS administrations significantly. Combination treatments of a cancer-drug Temozolomide and these GIC/GSC-differentiation inhibitors suppressed glioma progression, increased the chemosensitivities, and led the longer survival of mouse xenograft-models. Functional integrated proteomics for the first time demonstrates that the GIC/GSC induces the specific proteoglycans to regulate GIC/GSC stemness/differentiation via the integlin signalings which may be a clinical target against malignant gliomas.</Description>
    <AnnouncementDate>2018-11-30</AnnouncementDate>
  </Project>
  <presetSummary>
    <Species>
      <PresetElement id="9606" value="Homo sapiens (Human)"/>
    </Species>
    <Instrument>
      <PresetElement id="MS:1000932" value="TripleTOF 5600"/>
    </Instrument>
    <Modification>
      <PresetElement id="MOD:01710" ontologyName="iTRAQ8plex reporter+balance reagent N-acylated residue" value="iTRAQ8plex (K)"/>
      <PresetElement id="MOD:01712" ontologyName="iTRAQ8plex reporter+balance reagent acylated N-terminal" value="iTRAQ8plex (N-term)"/>
      <PresetElement id="MOD:00719" ontologyName="L-methionine sulfoxide" value="Oxidation (M)"/>
      <PresetElement id="MOD:00110" ontologyName="L-cysteine methyl disulfide" value="Methylthio (C)"/>
    </Modification>
  </presetSummary>
  <Contact>
    <Name>Akiko Nambu</Name>
    <Affiliation>Kumamoto University</Affiliation>
    <PrincipalInvestigator>Norie Araki</PrincipalInvestigator>
  </Contact>
  <Relation>
    <Keywords>glioblastoma, glioma initiating/stem cell, cancer stem cells, stemness, differentiation</Keywords>
    <PubMed/>
  </Relation>
  <FileList>
    <File id="f_0000511427">
      <Name>110107_TT55-0053_E8.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511428">
      <Name>110107_TT55-0053_D2.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511429">
      <Name>110107_TT55-0053_D3.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511430">
      <Name>110107_TT55-0053_D5.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511431">
      <Name>110107_TT55-0053_D6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511432">
      <Name>110107_TT55-0053_D7.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511433">
      <Name>110107_TT55-0053_D8.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511434">
      <Name>110107_TT55-0053_E1.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511435">
      <Name>110107_TT55-0053_E4.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511436">
      <Name>110107_TT55-0053_E6.wiff</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511437">
      <Name>110107_TT55-0053_D2.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511438">
      <Name>110107_TT55-0053_D3.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511439">
      <Name>110107_TT55-0053_D5.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511440">
      <Name>110107_TT55-0053_D6.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511441">
      <Name>110107_TT55-0053_D7.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511442">
      <Name>110107_TT55-0053_D8.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511443">
      <Name>110107_TT55-0053_E1.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511444">
      <Name>110107_TT55-0053_E4.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511445">
      <Name>110107_TT55-0053_E6.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511446">
      <Name>110107_TT55-0053_E8.wiff.mtd</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511740">
      <Name>110107_TT55-0053_20161102.group</Name>
      <Type>result</Type>
      <Profile/>
      <Format>other</Format>
      <Software>ProteinPilot</Software>
    </File>
    <File id="f_0000511750">
      <Name>110107_TT55-0053_E4.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511751">
      <Name>110107_TT55-0053_E1.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511752">
      <Name>110107_TT55-0053_D2.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511753">
      <Name>110107_TT55-0053_D3.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511754">
      <Name>110107_TT55-0053_D5.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511755">
      <Name>110107_TT55-0053_D6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511756">
      <Name>110107_TT55-0053_D7.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511757">
      <Name>110107_TT55-0053_D8.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511758">
      <Name>110107_TT55-0053_E8.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
    <File id="f_0000511759">
      <Name>110107_TT55-0053_E6.wiff.scan</Name>
      <Type>raw</Type>
      <Profile plex="iTRAQ113">
        <Sample id="S0000000896">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="1">iTRAQ113</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ114">
        <Sample id="S0000000906">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="2">iTRAQ114</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ115">
        <Sample id="S0000000907">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="3">iTRAQ115</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ116">
        <Sample id="S0000000908">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03A differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="4">iTRAQ116</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ117">
        <Sample id="S0000000909">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="5">iTRAQ117</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ118">
        <Sample id="S0000000910">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U sphere 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="6">iTRAQ118</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ119">
        <Sample id="S0000000911">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 2day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="7">iTRAQ119</label>
        </MS_mode>
      </Profile>
      <Profile plex="iTRAQ121">
        <Sample id="S0000000912">
          <species id="9606">Homo sapiens (Human)</species>
          <tissue id="BTO:0000142">brain</tissue>
          <celltype>cancer stem cell</celltype>
          <disease id="DOID:3068">glioblastoma</disease>
          <note>Glioma initiating/stem cell (GIC/GSC) clones were established from glioblastoma patient tissues. After successive cloning, each cloned cells were sub-cultured once a week, and the clones that could form spheres within a few days were subjected to the serial passages for more than 1- 2 years. All of GIC/GSC clones possess potentials of differentiation/promotion of glioblastoma. Under the routine sub passage, GIC/GSC03A or 03U clone on 2 day or 7 day culture in NSC medium without (sphere) or with 10% serum (differentiation) were used in this study.</note>
          <title>GIC/GSC03U differentiation 7day</title>
        </Sample>
        <Fractionation id="F0000000187">
          <title>SCX fraction</title>
          <subcellular replicate="">Whole</subcellular>
          <protein replicate=""/>
          <peptide replicate="">cation exchange</peptide>
          <note/>
        </Fractionation>
        <Enzyme_Mod id="E0000000174">
          <title>iTRAQ</title>
          <enzyme id="MS:1001251">Trypsin</enzyme>
          <fixedModification id="MOD:01710" name="iTRAQ8plex reporter+balance reagent N-acylated residue">iTRAQ8plex (K)</fixedModification>
          <taxonomy id="9606">Homo sapiens (Human)</taxonomy>
          <note/>
          <fixedModification id="MOD:01712" name="iTRAQ8plex reporter+balance reagent acylated N-terminal">iTRAQ8plex (N-term)</fixedModification>
          <variableModification id="MOD:00719" name="L-methionine sulfoxide">Oxidation (M)</variableModification>
          <fixedModification id="MOD:00110" name="L-cysteine methyl disulfide">Methylthio (C)</fixedModification>
        </Enzyme_Mod>
        <MS_mode id="M0000000181">
          <title>5600</title>
          <instrument id="MS:1000932">TripleTOF 5600</instrument>
          <instrumentMode>DDA-high res.</instrumentMode>
          <purpose>Relative quantification</purpose>
          <quantificationPlatform>Fragment ion (stable isotope labeling)</quantificationPlatform>
          <plex>8</plex>
          <note/>
          <label id="8">iTRAQ121</label>
        </MS_mode>
      </Profile>
    </File>
  </FileList>
  <AdditionalInformation/>
</jPostDataset>
